- Fuster V.
- Ryden L.E.
- Cannom D.S.
- et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines.
J Am Coll Cardiol. 2006; 48: 854-906- Dorian P.
- Guerra P.G.
- Kerr C.R.
- et al.
Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.
Circ Arrhythm Electrophsiol. 2009; 2: 213-214- Chen P.S.
- Pressley J.C.
- Tang A.S.
- et al.
New observations on atrial fibrillation before and after surgical treatment in patients with the Wolff-Parkinson-White syndrome.
J Am Coll Cardiol. 1992; 19: 974-981- Haissaguerre M.
- Fischer B.
- Labbe T.
- et al.
Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways.
Am J Cardiol. 1992; 69: 493-497- Paquette M.
- Roy D.
- Talajic M.M.
- et al.
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.
Am J Cardiol. 2000; 86: 764-768- Reynolds M.R.
- Ellis E.
- Zimetbaum P.
Quality of life in atrial fibrillation: measurement tools and impact of interventions.
J Cardiovasc Electrophysiol. 2006; 19: 762-768- Kannel W.B.
- Wolf P.A.
- Benjamin E.J.
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.
Am J Cardiol. 1998; 82: 2N-9N- Benjamin E.J.
- Levy D.
- Vaziri S.M.
- et al.
Independent risk factors for atrial fibrillation in a population-based cohort.
JAMA. 1994; 271: 840-844- Kannell W.B.
- Abbot R.D.
- Savage D.D.
- et al.
Epidemiologic features of chronic atrial fibrillation.
N Engl J Med. 1982; 306: 1018-1022- Wolf P.A.
- Dawber T.R.
- Thomas Jr, H.E.
- et al.
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study.
Neurology. 1978; 28: 973-977The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba Follow-up Study.
Am J Med. 1995; 98: 476-484- Verdecchia P.
- Reboldi G.P.
- Gattobigio R.
- et al.
Atrial fibrillation in hypertension.
Hypertension. 2003; 41: 218-223- Healey J.S.
- Connolly S.J.
Atrial Fibrillation: hypertension as a causative agent, risk factor for complications and potential therapeutic target.
Am Heart J. 2003; 91: 9G-14G- Krahn A.D.
- Klein G.J.
- Kerr C.
- et al.
How useful is thyroid function testing in patients with recent-onset atrial fibrillation?.
Arch Intern Med. 1996; 156: 2221-2224- Sharma A.D.
- Klein G.J.
- Guiradon G.M.
- et al.
Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway.
Circulation. 1985; 72: 161-169- Skanes A.C.
- Krahn A.D.
- Yee R.
- et al.
Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing.
J Am Coll Cardiol. 2001; 38: 167-172- Sweeney M.O.
- Bank A.J.
- Nsah E.
- et al.
Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
N Engl J Med. 2007; 357: 1000-1008- Healey J.S.
- Toff W.D.
- Lamas G.A.
- et al.
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data.
Circulation. 2006; 114: 11-17- Sweeny M.O.
- Hellkamp A.S.
- Ellenbogen K.A.
- et al.
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
Circulation. 2003; 107: 2932-2937- Ntep-Gweth M.
- Zimmermann M.
- Meiltz A.
- et al.
Atrial fibrillation in Africa: clinical characteristics, prognosis and adherence to guidelines in Cameroon.
Europace. 2010; 12: 482-487- Kanagala R.
- Murali N.S.
- Friedman P.A.
- et al.
Obstructive sleep apnea and the recurrence of atrial fibrillation.
Circulation. 2003; 107: 2589-2594- Wang T.J.
- Parise H.
- Levy D.
- et al.
Obesity and the risk of new-onset atrial fibrillation.
JAMA. 2004; 292: 2471-2477- Conen D.
- Tedrow U.B.
- Cook N.R.
- et al.
Alcohol consumption and risk of incident atrial fibrillation in women.
JAMA. 2008; 300: 2489-2496- Heuzey J.Y.
- Breithardt G.
- Camm A.J.
- et al.
The RECORDAF study: design, baseline data and profile of patients according to chosen treatment strategy for atrial fibrillation.
Am J Cardiol. 2010; 105: 687-693- Molina L.
- Mont L.
- Marrugat J.
- et al.
Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study.
Europace. 2008; 10: 618-623- Hackman D.G.
- Khan N.A.
- Hemmelgarn B.R.
- et al.
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
Can J Cardiol. 2010; 26: 249-258- Quinn R.R.
- Hemmelgarn B.R.
- Padwal R.S.
- et al.
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1 - blood pressure measurement, diagnosis and assessment of risk.
Can J Cardiol. 2010; 26: 241-248- Kim D.D.
- Young S.
- Cutfield R.
- et al.
A survey of thyroid function test abnormalities in patients presenting with atrial fibrillation and atrial flutter to a New Zealand district hospital.
N Z Med J. 2008; 121: 82-86- Atrial Fibrillation Investigators
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.
Arch Intern Med. 1994; 154: 1449-1457- Wolf P.A.
- Abbot R.D.
- Kannel W.B.
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
Stroke. 1991; 22: 983-988- Wolf P.A.
- Abbot R.D.
- Kannel W.B.
Atrial fibrillation: a major contributor to stroke in the elderly.
Arch Intern Med. 1987; 147: 1561-1564Atrial fibrillation and stroke.
Stroke. 1994; 25: 1337-1341- Poli D.
- Antonucci E.
- Grifoni E.
- et al.
Stroke risk in atrial fibrillation patients on warfarin: predictive ability of risk stratification schemes for primary and secondary prevention.
Thrombo Haemost. 2009; 101: 367-372- Hart R.G.
- Pearce L.A.
- Aquilar M.I.
Meta-analysis: anti-thrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.
Ann Intern Med. 2007; 146: 857-867- Connolly S.J.
- Pogue J.
- Hart R.G.
- et al.
- ACTIVE Investigators
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
N Engl J Med. 2009; 30: 2066-2078Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.
Ann Intern Med. 1999; 131: 492-501Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost-effectiveness data.
Thrombo Haemost. 2009; 99: 295-304- Stroke Risk in Atrial Fibrillation Working Group
Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.
Stroke. 2008; 39: 1901-1910- Connolly S.J.
- Pogue J.
- Eikelboom J.
- et al.
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centres and countries as measured by time in therapeutic range.
Circulation. 2008; 118: 2029-2037- Cairns J.A.
- Connolly S.
- McMurtry S.
- Stephenson M.
- Talajic M.
- CCS Atrial Fibrillation Guidelines Committee
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Can J Cardiol. 2011; 27: 74-90- Healey J.S.
- Hart R.G.
- Pogue J.
- et al.
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE-W).
Stroke. 2008; 39: 1482-1486- Connolly S.J.
- Ezekowitz M.D.
- Yusuf S.
- et al.
Dabigatran versus warfarin in patients with atrial fibrillation.
N Engl J Med. 2009; 361: 1139-1151- Hart R.G.
- Pearce L.A.
- Rothbart R.M.
- et al.
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy.
J Am Coll Cardiol. 2000; 35: 183-187A comparison of rate control and rhythm control in patients with atrial fibrillation.
N Engl J Med. 2002; 347: 1825-1833- Rivero-Ayerza M.
- Scholte Op Reimer W.
- Lenzen M.
- et al.
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey.
Eur Heart J. 2008; 29 (): 1618-1624